Boston Scientific (BSX) Announces Positive Data from First HeartLogic Trial in Predicting HF Decompression

November 16, 2016 1:37 PM EST Send to a Friend
Boston Scientific (NYSE: BSX) announced results from the first clinical trial evaluating the performance of the HeartLogic Heart Failure Diagnostic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login